SALT LAKE CITY--(BUSINESS WIRE)--The U.S. Patent and Trademark Office has granted U.S. Patent No. 7,670,832, reaching claims that apply to most of the real-time PCR instruments on the market. Idaho Technology, Inc. is the exclusive licensee of this patent. This most recent patent to issue in the company’s growing portfolio relates to methods of performing nucleic acid analysis in the presence of a fluorescent dye.